IMATINIB

Description

Imatinib – Targeted Therapy for Leukemia and Gastrointestinal Stromal Tumors (GIST)

Imatinib is a prescription targeted cancer therapy that belongs to the class of tyrosine kinase inhibitors (TKIs). It is primarily used in the treatment of chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL) with Philadelphia chromosome positivity, and gastrointestinal stromal tumors (GIST). By blocking the activity of abnormal tyrosine kinases such as BCR-ABL, c-KIT, and PDGFR, Imatinib prevents uncontrolled cancer cell growth.

At Oncomed Pharmacy, we provide authentic Imatinib tablets from trusted manufacturers, ensuring patients receive safe, effective, and high-quality oncology medicines.

Key Features of Imatinib

• Indications:

o Chronic myeloid leukemia (CML)

o Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)

o Gastrointestinal stromal tumors (GIST)

o Myelodysplastic/myeloproliferative diseases (MDS/MPD)

o Hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL)

o Dermatofibrosarcoma protuberans (DFSP)

• Formulation: Oral tablets available in multiple strengths (e.g., 100 mg, 400 mg).
• Mechanism of Action: Selective tyrosine kinase inhibitor that blocks abnormal BCR-ABL and c-KIT proteins, reducing cancer cell proliferation.
• Patient Benefit: Convenient oral targeted therapy with high response rates in leukemia and solid tumors.

Why Buy Imatinib from Oncomed Pharmacy?

• 100% genuine and quality-assured targeted therapy medicines.
• Competitive prices with countrywide delivery.
• Available in multiple strengths for personalized treatment.
• Trusted oncology pharmacy specializing in hematology and solid tumor medicines.

Uses of Imatinib

• First-line therapy for chronic myeloid leukemia (CML).
• Standard targeted therapy for GIST after c-KIT mutation detection.
• Treatment of Ph+ ALL and resistant or relapsed cases.
• Effective in rare cancers like DFSP and HES/CEL.